Following people with multiple sclerosis over many years to learn about their disease
Observes people with multiple sclerosis over many years to understand how the disease changes.
Key facts
- Who runs it
- University of Pittsburgh
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Registry title
- Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
- Status
- Recruiting
- People taking part
- 7,500 people, planned
- Started
- Dec 2016
- Expected to end
- Jan 2047
- Type of study
- Observational, 2 groups
- Record updated
- 29 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with multiple sclerosis or related disorders, and also healthy volunteers as controls. All must be 7 years or older.
- Age
- 7 years or older
- Sex
- All sexes can join.
- Disease stage
- Multiple sclerosis or related disorders. This includes a first episode of nervous system demyelination with a positive MRI scan, or MS-like MRI scans with no symptoms.
Main reasons for not taking part
- The record lists no exclusion criteria.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Inclusion criteria for MS patients include:; Age 7 years or older; Willing and able to provide consent (for >=18 years) or assent with permission from at least one of the child's parents (for <18 years); Diagnosis of multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease
- For healthy controls:; Age 7 years or older; Willing and able to provide consent (for >=18 years) or assent with permission from at least one of the child's parents (for <18 years); No known personal history of multiple sclerosis or related disorders; No other chronic diseases; Family members, unrelated household controls, or controls from the general population could be eligible; There is no exclusion criteria
Where in United States
- University of PittsburghPittsburgh, United StatesContact: Zongqi Xia, MD, PhDTaking people
About the trial
What the trial wants to find out
In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neurological disorder, this observational cohort study will span a 30-year time frame.
The 2 groups in the trial
- People with Multiple Sclerosis or Related Disorders
Individuals must be 7 years or older, diagnosed with multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease
- People without Multiple Sclerosis or Related Disorders
Control participants must be 7 years or older, have no known personal history of multiple sclerosis or related disorders, no other chronic disease, and can be a family member, unrelated household control, or control from the general population.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
- Plain-language title
- Following people with multiple sclerosis over many years to learn about their diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 29 December 2025